Needham Reiterates Buy Rating on RxSight Inc. (RXST) Feb 26, 2026 06:09AM
RxSight Inc. (RXST) PT Raised to $12 at Needham Nov 6, 2025 04:54AM
Needham Reiterates Buy Rating on RxSight Inc. (RXST) Jul 9, 2025 06:06AM
Needham Reiterates Buy Rating on RxSight Inc. (RXST) Apr 3, 2025 06:34AM
RxSight, Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference Mar 25, 2025 04:05PM


Jan 13, 2025 06:11AM Needham Reiterates Buy Rating on RxSight Inc. (RXST)
Sep 13, 2024 06:34AM Needham Reiterates Buy Rating on RxSight Inc. (RXST)
Aug 20, 2024 05:13AM RxSight Inc. (RXST) PT Raised to $66 at Needham, Added to Conviction List
Aug 6, 2024 07:17AM RxSight Inc. (RXST) PT Lowered to $54 at Needham
May 7, 2024 06:41AM RxSight Inc. (RXST) PT Raised to $75 at Needham
Mar 27, 2024 04:05PM RxSight, Inc. to Participate in the 23rd Annual Needham Virtual Healthcare Conference
Feb 29, 2024 05:18AM RxSight Inc. (RXST) PT Raised to $64 at Needham, '4Q23 Showed Solid Revenue Growth And Margin Improvement'
Apr 5, 2023 04:05PM RxSight, Inc. to Present at the Needham Healthcare Conference
Apr 5, 2023 04:05PM RxSight, Inc. to Present at the Needham Healthcare Conference
Apr 8, 2022 05:38AM UPDATE: Needham & Company Starts RxSight Inc. (RXST) at Buy
Mar 28, 2022 04:05PM RxSight, Inc. to Present at the Needham Virtual Healthcare Conference
Mar 28, 2022 04:05PM RxSight, Inc. to Present at the Needham Virtual Healthcare Conference